Cingulate (CING) Cash from Financing Activities (2021 - 2025)
Cingulate's (CING) quarterly Cash from Financing Activities came in at $8.6 million in Q4 2025, up 33.17% on a YoY basis from $6.4 million in Q4 2024, and up 487.07% quarter-over-quarter from $1.5 million in Q3 2025.
Powered by 
Analysis
Cingulate (CING) Cash from Financing Activities (2021 - 2025) Analysis & Trends
Cingulate (CING) has reported Cash from Financing Activities for 5 consecutive years, with $8.6 million the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Cash from Financing Activities rose 33.17% year-over-year to $8.6 million; the trailing twelve-month figure through Dec 2025 stood at $16.1 million (down 47.6% YoY), and the FY2025 full-year result was $16.1 million, down 47.6% from the prior year.
- Cash from Financing Activities climbed to $8.6 million in Q4 2025 per CING's latest filing, from $1.5 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $19.9 million in Q4 2021 and bottomed at -$89780.0 in Q4 2022.
- Historically, Cash from Financing Activities has averaged $4.4 million across 5 years, with a median of $2.6 million in 2023.
- The sharpest annual moves came in 2022 and 2024: Cash from Financing Activities plunged 100.45% in 2022, then soared 252377.63% in 2024.
- Over 5 years, Cash from Financing Activities stood at $19.9 million in 2021, then slumped by 100.45% to -$89780.0 in 2022, then soared by 1008.26% to $815434.0 in 2023, then jumped by 690.89% to $6.4 million in 2024, then jumped by 33.17% to $8.6 million in 2025.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered $8.6 million, $1.5 million, and $4.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | -3.66 Bn |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | -2.63 Bn |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | -2.10 Bn |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | 2.42 Bn |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | -6.05 Mn |
| 10 | Cingulate | 72.81 Mn | 72.81 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 8.59 Mn |
| Sep 30, 2025 | 1.46 Mn |
| Jun 30, 2025 | 4.18 Mn |
| Mar 31, 2025 | 1.92 Mn |
| Dec 31, 2024 | 6.45 Mn |
| Sep 30, 2024 | 13.40 Mn |
| Jun 30, 2024 | 1.08 Mn |
| Mar 31, 2024 | 9.89 Mn |
| Dec 31, 2023 | 815,434.00 |
| Sep 30, 2023 | 5.93 Mn |
| Jun 30, 2023 | 3.21 Mn |
| Mar 31, 2023 | -3,920.00 |
| Dec 31, 2022 | -89,780.00 |
| Sep 30, 2022 | 5.00 Mn |
| Jun 30, 2022 | -3,745.00 |
| Mar 31, 2022 | -3,682.00 |
| Dec 31, 2021 | 19.91 Mn |
| Sep 30, 2021 | 3.47 Mn |
| Jun 30, 2021 | 1.81 Mn |
| Mar 31, 2021 | 1.35 Mn |
API Access
Cingulate Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=CING&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "CING", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=CING&period=max&api_key=YOUR_API_KEY");
const data = await res.json();